Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues
Operating expenses
Research and development	245,625	2,590,645
General and administrative	657,911	556,892
Total operating expenses	903,536	3,147,537
Loss from operations	(903,536)	(3,147,537)
Other income (expenses)
Change in fair value of warrant liability	37,311	(562,918)
Interest income	255	556
Total other income (expenses)	37,566	(562,362)
Net loss	$ (865,970)	$ (3,709,899)
Weighted average shares outstanding - basic	660,928	67,211
Weighted average shares outstanding - diluted	660,928	67,211
Loss per share - basic	$ (1.31)	$ (55.20)
Loss per share - diluted	$ (1.31)	$ (55.20)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.